U.S. Laboratory Disposable Products Market Share Analysis Report, 2025-2034
The U.S. laboratory disposable products market size was exhibited at USD 1.85 billion in 2024 and is projected to hit around USD 4.03 billion by 2034, growing at a CAGR of 8.1% during the forecast period 2025 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 2.00 Billion |
| Market Size by 2034 | USD 4.03 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 8.1% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Product, Material, End use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Key Companies Profiled | Cardinal Health; Thomas Scientific; Medicus Health; Therapak, an Avantor company.; Dynarex Corporation.; Thermo Fisher Scientific Inc.; MCKESSON CORPORATION; Medline Industries, Inc.; BD; Agilent Technologies, Inc. |
The increasing prevalence of chronic diseases and the rising number of diagnostic tests are boosting the demand for laboratory disposables. In addition, advancements in biotechnology and pharmaceutical research are resulting in the higher adoption of disposable products to ensure contamination-free environments. The growing emphasis on infection control and safety in healthcare settings further propels the market, as disposable products help minimize the risk of cross-contamination.
The COVID-19 pandemic has heightened the awareness and necessity for disposable laboratory products, contributing to their sustained demand. Also, the convenience and cost-effectiveness of disposable products compared to reusable ones are significant factors encouraging their adoption in various laboratory settings.
Laboratory disposable products are manufactured from materials such as paper, cotton, plastics, and polystyrene foam. These consumable items help prevent various types of contamination in laboratory environments. Utilizing disposable products has led to better results in clinical trials, tests, and experiments. Their single-use property reduces the need for re-processing, and many of these products are sterilized to avoid further contamination.
Growth in the medical sector and the rise in medical tourism have driven market growth in the U.S. An increased focus on patient safety has led hospitals and laboratories to adopt disposable products, which help avoid hospital-acquired infections (HAIs). Both government and private medical institutes invest heavily to improve patient safety and perform accurate treatments, tests, and diagnoses. This has increased the demand for products such as gloves, test tubes, vials, containers, and tissue collectors. Major companies are targeting the launch of technologically advanced and efficient products to improve the performance of medical procedures. Therefore, growth in the medical sector and an increased focus on patient safety and accurate treatments have driven the growth of the laboratory disposable products market in the U.S.
The specimen containers segment dominated the market in 2024 with a share of 40.3% due to the critical role specimen containers play in the collection, storage, and transportation of biological samples. These containers are essential in ensuring the integrity and sterility of specimens, which is crucial for accurate diagnostic testing and research. The widespread use of specimen containers across various medical and research facilities, including hospitals, clinics, and laboratories, underscores their importance. Additionally, the increasing prevalence of chronic diseases and the rising number of diagnostic tests have further fueled the demand for these containers. Innovations in material science have also led to the development of more durable and user-friendly specimen containers, enhancing their adoption.
The tissue collectors segment is expected to grow at a CAGR of 9.3% over the forecast period. The growing emphasis on cancer research, personalized medicine, and advancements in tissue engineering are key drivers of this segment’s growth. As the demand for precise and reliable tissue samples increases, so does the need for high-quality tissue collectors. Technological advancements have led to the development of more efficient and sterile tissue collection devices, which are crucial for maintaining sample integrity. Furthermore, the increasing number of surgical procedures and biopsies performed in medical facilities contributes to the rising demand for tissue collectors.
The plastics segment accounted for a revenue share of 54.0% in 2024 owing to the high degree of versatility and cost-effectiveness plastics offer, making them an ideal choice for a wide range of laboratory applications. They are lightweight, durable, and resistant to breakage, which enhances their usability in various experimental and diagnostic procedures. Additionally, the ease of mass production and the ability to mold plastics into different shapes and sizes cater to the diverse needs of laboratory settings. The increasing emphasis on single-use products to prevent contamination and ensure sterility further boosts the demand for plastic disposables.
The glass segment is expected to grow at a CAGR of 8.3% over the forecast period. Glass has long been a staple in laboratory environments due to its chemical inertness, transparency, and ability to withstand high temperatures and pressures. These properties make glass an indispensable material for applications requiring precise measurements and reactions, such as in analytical chemistry and microbiology. The anticipated growth in this segment can be linked to advancements in glass manufacturing technologies that enhance durability and reduce costs.
The Contract Research Organizations (CROs) segment dominated the market in 2024 primarily driven by the increasing outsourcing of research and development activities by pharmaceutical and biotechnology companies to CROs. These organizations provide a wide range of services, including clinical trials, preclinical research, and regulatory support, which require extensive use of laboratory disposable products. The growing complexity of drug development processes and the need for specialized expertise have further propelled the demand for CRO services. Additionally, the cost-efficiency and scalability offered by CROs make them an attractive option for companies looking to streamline their R&D operations. The stringent regulatory requirements and the need for high-quality, sterile laboratory disposables to ensure the accuracy and reliability of research outcomes also contribute to the segment’s growth.
The hospital segment is expected to grow at a CAGR of 8.7% from 2024 to 2030. Hospitals are major consumers of laboratory disposable products due to their extensive diagnostic and therapeutic activities. The rising incidence of chronic diseases, increasing surgical procedures, and the growing emphasis on infection control are key factors driving the demand for disposable products in hospitals. These products, including syringes, specimen containers, and tissue collectors, are essential for maintaining sterility and preventing cross-contamination. The ongoing advancements in medical technology and the adoption of more sophisticated diagnostic tools further boost the need for high-quality disposables. Additionally, the increasing focus on patient safety and the implementation of stringent healthcare regulations underscore the importance of using reliable disposable products in hospital settings.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. laboratory disposable products market
By Product
By Material
By End Use
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers